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ABSTRACT 
A Study on Prevalence of Diabetic Foot Ulcer and Quality of Life of Type 
2 Diabetes Mellitus Patients in a Multi-Specialty Hospital 
Aim: The present study aim is to assess the prevalence of diabetic foot ulcer 
and the quality of life among type 2 diabetes mellitus. 
Methods: A prospective observational study was conducted in 146 
consecutive patients with type 2 diabetes mellitus in a multispeciality hospital. 
The demographic details were collected using data collection form and ferrans 
and powers QLI index questionnaire was used to assess the Quality of Life. 
The collected data from the subjects were analyzed by using ANOVA. 
Results: The results showed that the prevalence of diabetic foot ulcer was 
20.47% and the mean age of patient with diabetic foot ulcer was 55.5 ± 3.03 
years. As per the study, Quality of Life of subjects were improved statistically 
with patient counseling in health and functioning domain (p<0.05).  The 
patients with more than 15 years of diabetes mellitus had no significant 
improvement in their quality of life. 
Conclusion: The study concluded that 20.47% diabetic patients have foot 
ulcer. With regular patient counseling, maintenance of diet and exercise with 
good patient compliance improves the QOL of patients in day-to-day activities. 
Key words: Diabetic foot ulcer, Quality of life, Type 2 diabetes mellitus. 
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1.   INTRODUCTION 
 Diabetes mellitus (DM) is a chronic metabolic disorder characterized by 
increased glucose levels in the blood which contributes in the development of 
microvascular, macrovascular and neuropathic complications. Diabetes is 
emerging as a major health problems which increases the rate of morbidity 
and mortality.(1) According to WHO estimation, the global prevalence of 
diabetes is increasing at a rate of more than 120%. In 1995 there were 135 
million people affected with diabetes mellitus, in 2000 the number rose to 171 
million. World wide the projected estimate of the people likely to get affected 
with diabetes by 2025 will be 300 million and by 2030 will be 366 million. In 
India it was 31.7 million in 2000 and will be increased as 79.4 million in 
2030.(2) The diabetes epidemic and diabetes rates in South Asia vary from 
3.3% in Nepal to 10% in India.(3) 
 World health organization estimates 60% of diabetic population will be 
from developing countries of Asia by 2025. The highest regional prevalence is 
reported as 10.2% in North America followed by 6.7% in south Asia. The most 
important demographic change is the increase in the proportion of people >65 
years of age prone to diabetes across the world. According to the 20th Annual 
World Diabetes Congress(AWDC), 50.8 million of individuals have diabetes in 
India. India is one of the top ten country for numbers of people aged 20-79 
years with diabetes in 2010 and 2030. The prevalence of diabetes is 
increased due to change in lifestyle modification such as decreased physical 
activity and increased obesity. 
 International diabetic federation estimates that diabetes represents the 
fourth leading cause of global deaths.(2) 
 According to the Lancet study, China, India and USA are the top three 
countries with a large number of diabetic population. In 1980, 20.4 million in 
China was increased to 102.9 million in 2014, the rise has been equally 
dramatic in India from 11.9 million in 1980 to 64.5 million in India. Prevalence 
of diabetes has more than doubled for men in China and India (3.5 percent to 
9.9 per cent in China and 3.7 per cent to 9.1 per cent in India). It has also 
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increased by 50 per cent among women in China (5.0 per cent to 7.6 per 
cent) and 80 per cent among women in India (4.6 percent to 8.3 percent). The 
prevalence of type 2 diabetes is projected to rise from 246 million people to 
380 million people by 2025 worldwide. It is representing as 7.1% of global 
adult population.(4) 
 Diabetes have both long term and short term complications include 
macrovascular (ischemic heart disease, stroke, peripheral vascular disease) 
and microvascular (diabetic neuropathy, diabetic nephropathy, diabetic 
retinopathy). These in turn have a negative impact on health related quality of 
life(5) 
 The prevalence of diabetes is increasing worldwide resulting in foot 
complications, which leads to poor quality of life and increased cost of living. 
More than 60% of diabetic patients are affected by neuropathy. Overall, the 
life expectancy is about 7 to 10 years shorter than for people without diabetes 
because of increased mortality from diabetic complication.  
 Among diabetes mellitus complications, foot ulceration is the most 
commonly affected and approximately 15% of diabetic patients suffer during 
their life time. All people with diabetes have a chance to develop foot pain and 
foot ulcer, but it can be easily prevented by good foot care maintenance. 
 According to the file documented on 1999, 20th century, there was 
inadequate evidence on trials or data related to prevalence, morbidity and 
health care costs of diabetic foot disease. But on 21st century, there are lot of 
information regarding diabetic foot ulcer particularly in these decades. Foot 
ulcer plays an important role in the lower extremity amputation that too in 
adults with diabetes mellitus. By 2030 it is estimated that more than 550 
million people around the world will have diabetes. Approximately 25% of 
these patients will develop foot ulcers during their lifetime, which requires 
advanced diabetic wound treatment to prevent complications.  
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 Type 2 diabetes affect the patients general health and well-being in 
various ways. For example, severe diet restriction and daily intake of oral 
medication or insulin may adversely affect an individuals health related quality 
of life. In addition, the long-term complications of diabetes, such as 
nephropathy, neuropathy, heart disease, and stroke, with their considerable 
impact on health, may also have a negative effect on quality of life.(5) Some 
patients may have low energy levels, insomnia(sleep disturbances), physical 
dysfunction and many other problems.(6) 
      
 WHO defines health as being not only the absence of disease and 
infirmity but also presence of physical, mental and social well being.(2) 
Assessment of quality of life is considered as important measure of outcome 
in chronic disease management.(7) 
 
 QOL as the persons perception and understanding of his living 
conditions in terms of culture and values of the society in line with goals, 
expectations, standards and interests of individuals.(8) QOL is defined by 
Ferrans as “a person’s sense of well-being that stems from satisfaction or 
dissatisfaction with the areas of life that are important to him/her.(9) 
 
 It is very important to measure the quality of life in type 2 diabetes 
mellitus patients having foot ulcer. Because to know how much they are 
satisfied and/or dissatisfied with their life in health and functioning domain, 
social and economical domain, psychological domain and family domain. 
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1.1 DIABETES MELLITUS 
1.1.1 DEFINITION 
 Diabetes mellitus [DM] is a group of metabolic disorder characterized 
by hyperglycemia and associated with abnormalities in carbohydrate, fat and 
protein metabolism. 
1.1.2 Etiology   
Type 1- genetic factors,  
Type 2-Many people with type 2 diabetes have a family member affected with 
either type 2 diabetes or other medical problems associated with diabetes, 
such as high cholesterol levels, high blood pressure, or obesity. 
 The lifetime risk of developing type 2 diabetes is 5 to 10 times higher in 
first-degree relatives like sister, brother, daughter, son of a person with 
diabetes compared with a person with no family history of diabetes. 
 Environmental conditions — Environmental factors such as what we 
intake and how activeness are combined with genetic causes, affect the risk 
of developing type 2 diabetes.  
1.1.3 Epidemiology 
 The International diabetes federation (IDF) estimates that 246 million 
adults worldwide have diabetes mellitus. The world prevalence of diabetes 
among adults (aged 20-75 years) was 6.4% in 2010, 285 million adults were 
affected and it will increase in 2030 as 7.7%, 439 million adults. Between 
2010 and 2030, there will be a 69% increase in adults number with diabetes in 
developing countries and 20% increase in developed countries.(10) It is known 
that approximately 90% of diabetic patients have type 2 diabetes mellitus.(11) 
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1.1.4 DIAGNOSIS  
 According to the World Health Organization, the diagnosis of diabetes 
mellitus had a criteria such as  
Fasting blood glucose testThe blood sugar level should be 7.0 mmol/L 
(126mg/dl). The report states that the diagnosis should be confirmed after two 
or three repetitions of  symptoms or blood glucose determination. 
Random blood sugar test The blood sample will be collected at a random 
time after last ate. The blood glucose level should be less than 200mg/dl or 
11.1 mmol/L. 
Heamoglobin A1C test  The blood sample will be collected and tested at any 
time of the day(before eating or after eating) measures the average blood 
sugar level over the past two to three months. Normal values for A1C are 4 to 
5.6 percent. The A1C test can be done at any time of day (before or after 
eating). 
Oral glucose tolerance test the blood sample will be collected after the fast 
for atleast eight hours or overnight and then drink a sugary solution and the 
blood glucose level will be measured after two hours. The blood sugar level 
less than 140mg/dl(7.8 mmol/L) is normal, 140 to 199 mg/dl(7.8 to 11 
mmol//L) is considered as prediabetes. This is sometimes referred to as 
impaired glucose tolerance. (10) 
 
1.1.5 CLASSSIFICATION 
 The WHO classification includes both clinical stages (normoglycemia, 
impaired glucose tolerance/impaired fasting glucose, diabetes) 
Type 1 -  beta cell destruction with little or no endogenous insulin secretory 
capacity. It is otherwise known as juvenile-onset diabetes, results from a 
cellular – mediated autoimmune destruction of the beta-cells of the pancreas. 
It is also due to autoimmune disorder. 
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Type 2 - ranges from relative insulin deficiency to disorders of insulin 
secretion and insulin resistance. The pancreas create more amount of insulin 
sometimes but the body is not able to use it effectively.(1) This diabetes goes 
undiagnosed for many years because the hyperglycemia develops gradually 
and at earlier stages not severe to notice any of the symptoms of diabetes. It 
is also a genetic disorder definitely having a family history. 
Other specific types –  
      Gestational diabetes 
      Genetic defects of beta cell function  
      Genetic defects in insulin secretion 
      Uncommon forms of immune mediated diabetes(10) 
1.1.6 SIGNS AND SYMPTOMS 
Polyuria 
Polydipsia 
Polyphagia 
Fatigue  
Blurred vision 
Recurrent vaginal infection 
Trouble in thinking and concentrating(10) 
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1.1.7 PHARMACOLOGICAL TREATMENT  
Oral hypoglycemic agents 
1. Biguanides - metformin                                                                  
2. Thiazolidinediones – pioglitazone, rosiglitazone 
3. Meglitinides – repa-g, nate-g 
4. Sulfonylureas - glipizide, gliclazide, glyburide, glimipride 
5. Alpha glucosidase inhibitor – acarbose, voglibose, miglitol 
6. DPP-4 inhibitors – vildagliptin, linagliptin, sitagliptin, saxagliptin, 
alogliptin 
7. GLP receptor agonist – exenatide, liraglutide 
8. SGLT 2 inhibitors – dapaglifozin, cangliflozin, ipragliflozin 
9. Dopamine D2 receptor agonist – bromocriptine 
10. Amylin analog – pramlintide 
11. Bile acid binding resin – colesevalam(24) 
Insulin therapy   
Short acting insulin - regular insulin and insulin analogues (asparte, lispro, 
glulisine) 
Intermediate acting insulin - neutral protamine hagedon(NPH) insulin and 
lente insulin 
Long acting insulin   -  ultralente insulin and protamine zinc insulin 
1.1.8 NON PHARMACOLOGICAL TREATMENT 
 Diet and Exercise 
 Smoking Cessation  
 Yoga 
 Physical activity 
 
  
Introduction  
 
A Study on Prevalence of Diabetic Foot Ulcer and Quality of Life of Type 2 Diabetes  
Mellitus Patients in a Multi-speciality Hospital Page 8 
1.2 DIABETIC FOOT ULCER 
 A diabetic foot ulcer is an open sore, no matter how large or deep that 
can develop anywhere on the foot or toes that lost the protective layer of the 
skin. Non traumatic lesions of the skin(partial or full thickness) on the foot of a 
person who has diabetes mellitus(12) 
1.2.1 ETIOLOGY: 
 The etiology of foot ulcer has many components. One of the past 
multicenter study reported that 63% of diabetic foot ulcer due to peripheral 
sensory neuropathy, trauma, and deformity. Some other factors includes 
ischemia, callus formation, and edema. Ulcers are the primary cause leads to 
amputation and many risk factor for foot ulcers are the predisposing factor for 
amputation.(46) Long term hyperglycemia impairs the immune system or 
immune response which in turn leads to poor healing of cuts and wounds. The 
most frequent underlying etiologies are neuropathy, trauma, deformity, high 
plantar pressures, and peripheral arterial disease. Neuropathy is often a 
predisposing factor to ulceration and amputation. Diabetic ulcers are most 
commonly caused by  
1. Poor circulation- a form of vascular disease in which blood doesn’t flow 
to the feet efficiently. 
2. High blood sugar (hyperglycemia)- slow down the healing process 
3. Nerve damage – loss of sensation, feels tingling and painful initially 
which results in painless wounds that can cause ulcers. 
4. Irritated or wounded feet -   dry skin is common and corns, calluses, 
cracking and bleeding wounds may occur. 
1.2.2 EPIDEMIOLOGY 
 Diabetic foot ulcer is one of the most common complication in diabetes 
patients which leads to hospitalization and in severe cases amputations 
required. Diabetic foot patients may also have other complications of 
diabetes. The prevalence of foot ulcer was as high as 11.6% by Centre For 
Disease Control And Prevention (CDCP) (2003) in united states. In a 
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population based study, USA reported 10.6% of diabetic foot ulcers.(14) 
Prevalence rate of diabetes in Indians is 2.4% in rural and 12-17% in urban 
population. Foot ulcers will occur in 5-10% of the diabetic population. 
Ulceration is the most common cause of amputation.(4) The various lower limb 
complications in diabetic patients are peripheral neuropathy, charcot 
arthropathy, foot ulcers, infections, and lower extremity amputations which 
may lead to hospitalization and disability among the diabetics.(4) 
 In India, prevalence of diabetic foot ulcer patients in a clinic population 
is 3% which is comparatively lower than western countries. The prevalence of 
foot complications such as peripheral vascular disease 5%, neuropathy 15% 
and infections 7.6%. In India, 55% of foot ulcers are neuropathy, 35% were 
neuro ischemic and 10% were ischemic(blood vessel involvement).(15) 
1.2.3 CLASSIFICATION OF DIABETIC FOOT LESIONS 
 There are 3 main classification system which is commonly used in the 
clinical diagnosis of foot ulcer. 
1. Wagner Meggit classification 
2. Depth- Ischemic classification 
3. University of texas classification 
Wagner meggit classification 
 The Wagner system assess ulcer depth and presence of osteomyelitis 
or gangrene by using the following grades: 
Grade 0 – no open lesion 
Grade 1 – superficial ulcer 
Grade 2 – Probing to tendon or capsule 
Grade 3 – Deep ulcer with osteomyelitis, abscess, or joint sepsis 
Grade 4 – local gangrene – fore foot or heels 
Grade 5 – gangrene of entire foot 
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Depth ischemic classification: 
 This is a modified system of wagner-meggit classification. The modified 
classification is used to distinguish between wound and vascularity of foot 
easily and more accurately to elucidate grade 2 and 3.(14) 
The university of texas system 
 This system assess the ulcer depth, the presence of wound infection, 
and the presence of clinical signs of lower-extremity ischemia. The grades of 
the UT system are as follows:  
Grading - description 
Grade 0 – pre or post ulcerative site that has healed 
Grade 1 – superficial wound not involving tendon, capsule, or bone 
Grade 2 – wound penetrating to tendon or capsule 
Grade 3 – wound penetrating to bone or joint 
Stages - description 
Stage A -  no infection or ischemia 
Stage B – infection present 
Stage C – ischemia present 
Stage D – infection and ischemia present.(16) 
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1.2.4 PATHOPHYSIOLOGY  
 More than 60% of foot ulcer is caused by neuropathy. It is a metabolic 
abnormalities induced by hyperglycemia. One of the common mechanism of 
action is polyol pathway. Hyperglycemic state increases the action of an 
enzyme aldose reductase and sorbitol dehydrogenase results in the 
conversion of intracellular glucose to sorbitol and fructose. 
Causative factors: 
 The casual pathways leading to the foot ulceration include several 
component causes, the most important one is peripheral neuropathy 
which leads to loss of sensation. 
 The second factor includes the higher plantar pressure which leads to 
joint deformity and joint immobility. 
 The third component cause is trauma, especially when repetitive. 
Contributory factors 
 Diabetes 
 Arthrosclerotic peripheral vascular disease 
1.2.5 SIGNS AND SYMPTOMS 
 Foot ulcers are a common complication of poorly controlled diabetes, 
forming as a result of skin tissue breaking down and exposing the layers 
underneath, commonly found on big toes, balls of feet and to the bones from 
the feet. 
 One of the first signs of a foot ulcer is drainage from foot that might 
stain stocks or leak out in shoes, unusual swelling, irritation, redness, odors 
from one or both feet. 
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Symptoms as follows; 
 Cellulitis, 
 Deep skin and soft tissue infections, 
 Acute osteomyelitis, 
 Chronic osteomyelitis. 
1.2.6 RISK FACTORS 
 The major two risk factors are peripheral neuropathy and poor glycemic 
control followed by other factors such as 
1. Poorly fitted shoes 
2. Not washing the feet regularly or thoroughly 
3. Improper trimming of nails  
4. Alcohol consumption 
5. Tobacco use(decreases the blood circulation) 
6. Obesity(18) 
1.2.7 TREATMENT 
 For obese people, extra pressure causes the foot pain. The choice of 
antibiotics should be based upon the severity and type of the infection and 
microorganisms.  
 Mild infections- oral antibiotics such as cephalexin, dicloxacillin, 
amoxicillin-clavulanate, or clindamycin are effective choices. If methicillin 
resistant staphylococcus aureus infection is suspected then clindamycin, 
trimethoprime-sulfamethoxazole, minocycline, or linezolid may be used. Gram 
negative aerobes and/or anaerobes- dual drug treatment- trimethoprime-
sulfamethoxazole + amoxicillin-clavulanate or clindamycin + fluoroquinolone 
such as levofloxacillin or moxifloxacin. 
 Moderate to severe infections - hospitalized for parenteral antibiotic 
therapy- nafcillin or oxacillin. 
 Moderate to severe infection with ischemia - ampicillin / sulbactum 
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 Life or limb threatening infection – ticarcillin / clavulanate or piperacillin 
/ tazobactum, with or without an aminoglycoside. 
 Surgical debridement - it is important in diabetic patients with chronic 
osteomyelitis. Debridement removes the infected, bony fragments which 
cannot be cured by antibiotics but can treat with antimicrobial therapy. In 
some cases, amputation is required.  
 Patients must try to control their glycemic levels in order to achieve an 
effective outcome through microbial eradication and tissue healing.(12) 
OTC TREATMENTS 
 Dressings containing silver or silver sulphadiazine cream 
 Polyhexamethylenebiguanide (PHMB) gel  or solutions 
 Iodine (either povidone or cadexomer) 
 Medical grade honey in ointment or gel form 
Six key factors in treating a diabetic wound. 
1. Initially wound assessment should be done on diabetic wounds - 
neuropathic, ischemic, and neuroischemic.  
2. Tissue debridement - removal of necrotic tissue from a wound will 
reduce pressure and stimulates wound healing.  
3. Infection control – due to high morbidity and mortality rates associated 
with diabetic wounds more aggressive forms of infection control are 
necessary. Oral and topical antibiotics are prescribed. 
4. Moisture balance – choice of dressing is important. Alginates, 
hydrocolloids, and films ischosed.  
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5. Pressure offloading – pressure reduction or pressure offloading is 
done. Total contact casting is a non-removable thing which distributes 
the pressure evenly throughout the leg to reduce healing times. TCC is 
not always best especially for infected wounds. Removable offloading 
devices used such as removable cast walkers, scotchcast boots, or 
healing sandals. 
6. Underlying factors - blood glucose levels, proper nutrition, high blood 
pressure, and smoking cessation. 
 
1.2.8 PREVENTIVE MEASURES 
1. Wash the feet everyday 
2. Keep the feet dry and moisturized 
3. Change the socks frequently 
4. Wear proper fitting shoes 
5. Trim the toe nails  
6. Off loading(18) 
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2. LITERATURE REVIEW 
Yusuf S et al., (2016) studied the prevalence and risk factor of diabetic foot 
ulcers in a regional hospital as an observational epidemiological study and it 
was concluded as to educate the patients with high risk foot to prevent them 
from diabetic foot ulcer and risk factors.(9) 
Sriram S et al., (2016) was conducted a prospective comparative study on 
impact of pharmaceutical care activities on diabetic patients at a private 
hospital and concluded that the patient counseling of disease, medications, 
modification of lifestyle improves the quality of life and glycemic control.(55) 
Timar R, et al., (2016) conducted the study on factors influencing the quality 
of life perception in patients with type 2 diabetes mellitus.’ Cross sectional 
study was conducted in 198 type 2 diabetic patients by using the 
questionnaires and concluded that the diabetic complications decrease the 
perception of quality of life in co-morbid state such as retinopathy, neuropathy 
and cardiac autonomic neuropathy.(14) 
Masoome Shahnavazi et al., (2016) studied the relationship between 
emotional intelligence and quality of life in hemodialysis patients’. A 
descriptive correlational study concluded that the emotional intelligence of the 
hemodialysis patients should be improved by training them so that quality of 
life in hemodialysis patients will be good.(8) 
Anand A et al., (2016)studied clinico-microbiological study of diabetic foot 
ulcer patients to identify risk factors and their correlation with prognosis in 
tertiary care hospital in India’ and concluded that male sex, smoking, 
neuropathy, 50 years of age and infection with Gram negative organisms 
were the most important risk factors for the development of diabetic foot.(62) 
Andres PR et al.,(2015) studied ‘Quality of life in type 2 diabetes mellitus 
patients requiring insulin treatment and concluded as scores of QOL in 
selected T2DM patient population did not differ from the those reported in 
studies that included patients from high-income countries where there is 
access to a high level of diabetes care and also  increase the healthcare 
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providers and awareness of the patients about their quality of life and helps to 
overcome the barriers that delay insulin treatment.(28) 
Asiye D Akyol et al., (2015) studied ‘Reliability and validity of Turkish version 
of Quality of life index in stroke patients’ concluded as the findings from this 
study support the validity, reliability and feasibility of the QOL among stroke 
patients.(24) 
Kahsu Gebrekirstos et al., (2015) conducted a study on prevalence and 
factors associated with diabetic foot ulcer the study was concluded with poor 
glycemic control, not taking care of foot properly and wearing inappropriate 
shoes were the main reasons to develop diabetic foot.(10) 
Miguel C M et al., (2015) studied ‘Health-related quality of life in patients with 
type 2 diabetes mellitus in a rural area.’ concluded the study with poor self-
perceived health-related quality of life(HRQOL) in type 2 diabetes mellitus 
patients.(1) 
Mugomri M et al., (2015) studied ‘Determinants of quality of life among the 
elderly living with arthritis in manonyane community, Lesotho.’ concluded the 
study with the pain and worries decrease the quality of life in the aspect of 
health and functioning and social and economic subscale.(16) 
Yazdanpanah L et al., (2015) studied literature review on the management of 
diabetic foot ulcer. The study was concluded that for the management of 
diabetic foot ulcer, glycemic control, wound debridement, offloading and 
surgery can be done.(58) 
V Jyothylekshmy et al (2015) conducted the study on epidemiology of 
diabetic foot complications in a podiatry clinic. Retrospective study concluded 
with Staphylococcus aureus is the main causative pathogen along with 
Pseudomonas aeruginosa and fluroquinolones were the antibiotics used 
empirically in this study.(46) 
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Bediluderibe et al., (2014) conducted a cross sectional study on ‘Prevalence 
and factors influencing diabetic foot ulcer among diabetic patients attending 
arbaminch hospital and concluded that patients with diabetes developed foot 
ulcer. Rural residence, duration of diabetes, occupation, mean arterial 
pressure, presence of co-morbidity are factors associated with diabetic foot 
ulcer.(12) 
Elhamghasemi et al., (2014) Studied ‘Quality of life in women with coronary 
artery disease and concluded as there was a significant relationship between 
QOL and educational level, marital status, income and duration of disease            
(p < 0.05).(6) 
Anumol Mathew et al., (2014) studied quality of life among type II diabetes 
mellitus patients in South India as a descriptive study with 100 patients and 
concluded with significance of incorporating techniques to improve the quality 
of life of type 2 diabetes mellitus patients by providing an information booklet 
to achieve a better quality of life.(68) 
Harish kumarsomappaet al., (2014) conducted a study with the objectives to 
assess Quality of life among type 2 diabetic patients and concludes that 
correlations revealed that there is positive correlation with QOL domains and 
all the diabetic patients need improvement with proper treatment regimen 
ensures good glycemic control.(33) 
Leelavathi D Acharya et al., (2014) studied ‘Development and validation of 
quality of life assessment instrument for diabetic patients’ and concluded the 
study with MDQoL-17 questionnaire was similar to the established RAND-36 
and could be used as a tool to assess the quality of life in diabetic patients.(54) 
Abuawad S. S.Majed et al., (2013) conducted a study to assess the impact 
of DM on the health-related quality of life (HRQOL) of diabetic patients and 
concluded that DM disease has negative impact on HRQOL. Thus health care 
providers, particularly MOH health care providers must address its social 
consequences.(71) 
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P. Tamilselvi et al., (2013) conducted A descriptive study to assess the 
knowledge regarding diabetic foot ulcer among diabetic clients in a selected 
hospital and concluded that there is need to educate people regarding their 
disease to improve the health and quality of life of an individual.(34) 
Dr Amit Kumar C Jain et al., (2012) studied ‘A new classification of diabetic 
foot complications: A simple and effective teaching tool’ This was concluded 
with the newer classification can be used as a teaching tool helps in 
disseminating the knowledge about diabetic foot complications.(57) 
Kamal M Modh et al., (2011) studied an Impact of clinical pharmacist 
intervention on quality of life in type 2 diabetes mellitus’ and concluded that 
patient education showed positive impact on improvement of knowledge, 
attitude, and practice which reflected an improvement of health related quality 
of life and also improves the medication adherence behavior.(27) 
Al-Maskari MY et al., (2011) studied ‘Assessment of quality of life in patients 
with type 2 diabetes mellitus in Oman.’ The result reveals that patients having 
diabetes for less than 5 years have overall better Quality of life. Patients with 
HbA1c less than 8% showed significant increase in their glycemic control 
satisfaction score.(38) 
K.P. Arun et al., (2010) studied the impact on pharmaceutical care on the 
clinical outcome of diabetes mellitus among rural population and concluded as 
the pharmaceutical care program was effective in improving the clinical 
outcome and HRQOL of diabetes patients in rural India.(22) 
Adepu Ramesh et al., (2009) conducted a study on community pharmacy 
based patient education on quality of life in type 2 diabetes mellitus and 
concluded that   chronic diseases like diabetes affect the quality of life of 
patients and the education has a major role in improving the health care 
outcomes like glycemic control and quality of life. The quality of life score in all 
the four domains were observed and there was a significant decrease in the 
blood glucose level (p<0.05).(23) 
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Ghanassia E et al., (2008) studied ‘long-term outcome and disability of 
diabetic patients hospitalized for diabetic foot ulcer’. A prospective study for 
6.5 year follow up was conducted among 94 consecutive diabetic patients and 
the study concluded that the nephropathy was an important predictor of long-
term outcome.(59) 
Vijay Viswanathan et al., (2006) studied ‘Urban rural differences in the 
prevalence of foot complications in South Indian diabetic patients and 
concluded the reason for the high prevalence of foot infection could be 
attributed to greater prevalence of barefoot walking and prevalence of foot 
infection was higher among rural than urban patients amputations were also 
higher in rural than urban.(53) 
Li Chen Lin Grae Yau et al., (2006) studied ‘The efficacy of hyperbaric 
oxygen therapy in improving the quality of life in patients with wound 
problems. Finally the conclusion states that the patients quality of life has 
been improved when the wound is treated with HBOT.(17) 
Sarah Wild et al., (2004) conducted a study to estimate the prevalence of 
diabetes and the number of people of all ages with diabetes for years 2000 
and 2030 concluded as their findings indicate that the diabetes epidemic will 
continue even if levels of obesity remain constant. Given the increasing 
prevalence of obesity, it is likely that these figures provide an underestimate 
of future diabetes prevalence.(14) 
Probal K et al., (2003) studied to examine the long term outcome in terms of 
Amputation and mortality in new-onset diabetic foot ulcers stratified by 
etiology and concludes that foot ulcer not only affects the morbidity but also 
impairs the quality of life of patients and the mortality rate is reduced by 
decreasing the amputations in order to save both limb and life. The increased 
mortality appears to be independent of factors increasing ulcer risk.(5) 
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W. Ken Redekop et al., (2002) studied the health-related quality of life 
(HRQOL) and treatment satisfaction for patients with type 2 diabetes in the 
Netherlands and concluded the study with elderly patients, insulin therapy, 
obesity and the presence of complications are important determinants of 
HRQOL in patients with type 2 diabetes.(45) 
Samon O Oyiboet al., (2001) studied ‘A comparison of two diabetic foot ulcer 
classification systems. The wagner and the university of texas wound 
classification systems.’ Finally, for the group of study UT system was simple 
and easy to use and also better predictor of clinical outcome.(4) 
Edward J. Boykoet al., (1999) prospectively studied the effects of diabetes 
characteristics, foot deformity, behavioral factors, and neurovascular function 
on foot ulcer risk among 749 diabetic patients and concluded that certain foot 
deformities, reduced skin oxygenation and foot perfusion, poor vision, greater 
body mass, and both sensory and autonomic neuropathy independently 
influence foot ulcer risk, thereby providing support for a multi factorial etiology 
for diabetic foot ulceration.(37) 
Matthew J. Young et al., (1994) studied ‘The prediction of diabetic 
neuropathic foot ulceration using vibration perception thresholds.’ study was 
concluded that VPT is an effective predictor of the risk of foot ulceration in 
diabetes and therefore could be used to target foot-care education to those 
patients most likely to benefit and, thereby, possibly improve its 
effectiveness.(35) 
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3. AIM AND OBJECTIVES 
3.1 AIM 
 The aim of the study was to determine prevalence of diabetic foot ulcer 
and quality of life of type 2 diabetes mellitus patients. 
3.2 OBJECTIVES 
 To assess the prevalence of foot ulcer patients.    
 To determine the quality of life in T2DM patients using ferrans and 
powers quality of life index questionnaire. 
 To determine the factors associated with QOL in diabetic patients. 
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4. PLAN OF STUDY 
 The study was carried out for a period of 1 year from June 2016 to April 
2017. The proposed study has been designed as below. 
PHASES STEPS ACTIVITY 
PERIOD OF 
TIME 
 
 
 
 
 
 
 
 
 
 
PHASE I 
 
STEP 1 
 
Identification of target area for 
possible research 
 
 
 
 
 
 
 
 
 
2 months 
 
STEP 2 
 
Literature survey 
 
 
 
STEP 3 
 
Define criteria and standards 
 
 
 
STEP 4 
 
Designing of Data entry form 
 
 
 
STEP 5 
 
Selecting the  Questionnaire 
form 
 
 
 
PHASE II 
 
STEP 6 
 
Prospective collection of Data 
 
6 month 
 
PHASE III 
 
STEP 7 
 
Analysis of Data 
 
 
1 month 
 
PHASE IV 
 
STEP 8 
 
Presentation of Study Results 
 
1 month 
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5. METHODOLOGY 
5.1 STUDY TYPE 
 This was a Prospective Observational study 
5.2 STUDY SITE 
 The study was conducted in 300 bedded multispecialty hospital located 
in Elayampalayam. 
5.3 STUDY PERIOD 
 The study was approved (Ref No: SVCP/IEC/JUL/2016/07) by 
Institutional Ethical Committee of Vivekanandha Medical Care Hospital 
(Annexure-I). The study was carried out for the period of 1 year in the 
department of General Medicine. 
5.4 POPULATION SIZE 
 Total 262 patients were screened and based on inclusion and 
exclusion criteria, 146 patients were recruited in our study after getting the 
patient consent (Annexure-II & III) and the data was collected in specially 
designed data entry form (Annexure-IV). 
5.5 SELECTION CRITERIA 
Inclusion Criteria 
 Patients with type 2 diabetes mellitus 
 Both the gender 
 Age ≥ 30 years 
 Duration of diabetes ≥ 5 years 
 Both Inpatients and Outpatients 
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Exclusion criteria 
 Pregnancy and lactation 
 Age < 30 years 
 Duration of diabetes < 5 years 
 Critically ill patients 
5.6 SOURCES OF DATA 
 Patient’s case report 
 Quality of life index questionnaire 
5.7 STATISTICS 
          Data were analyzed by single factor ANOVA to detect significant 
differences between before and after patient counseling. Values are shown as 
the means ±SD and differences were considered statistically significant at         
p < 0.05. 
 
Results 
 
A Study on Prevalence of Diabetic Foot Ulcer and Quality of Life of Type  2 Diabetes  
Mellitus Patients in a Multi-speciality Hospital Page 25 
6. RESULTS 
 A total of 146 consecutive diabetic patients were selected as per 
inclusion and exclusion criteria. The demographic details, disease details and 
overall QOL scores and their subscale values were collected.                             
6.1AGE WISE DISTRIBUTION AMONG THE STUDY POPULATION 
 Among 146 cases, 5.48% (8 patients) were in the age group of 30-39 
years, 10.96% (16 patients) were in the age group of 40-49 years, 28.08% (41 
patients) were in the age group of 50-59 years, 32.19% (47 patients) were in 
the age group of 60-69 years, 19.86% (29 patients) were in the age group of 
70-79 years and 3.42% (5 patients) were in the age group of 80-89 years. The 
mean age of the study population was 60.07 ± 11.07 years (range 30-89 
years). (Table 1, Figure 1) 
TABLE 1 : AGE WISE DISTRIBUTION AMONG THE STUDY  POPULATION   
(n=146) 
Age (years) No of Patients Percentage 
30-39 8 5.48 % 
40-49 16 10.96% 
50-59 41 28.08% 
60-69 47 32.19% 
70-79 29 19.86% 
80-89 5 3.42% 
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FIGURE 1 : AGE WISE DISTRIBUTION OF THE STUDY  POPULATION   
(n=146) 
6.2 GENDER WISE DISTRIBUTION AMONG THE STUDY POPULATION 
 A total of 146 diabetic patients, males were 60.27% (83 patients) and 
females were 39.73% (58 patients). ((Table 2, Figure 2) 
 
TABLE 2 : GENDER WISE DISTRIBUTION AMONG THE STUDY 
POPULATION (n=146) 
Gender Number of Patients Percentage 
MALE 88 60.27 % 
FEMALE 58 39.73 % 
    
 
 
 
 
 
FIGURE 2 : GENDER WISE DISTRIBUTION AMONG THE STUDY 
POPULATION   (n=146) 
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Literate  
66% 
Illiterate  
34% 
6.3   LITERACY AMONG THE STUDY POPULATION 
Among 146 patients, 66.44% (97 patients) were literate and 33.56% (49 
patients) were illiterate. (Table 3, Figure 3) 
 
TABLE3: LITERACY AMONG THE STUDY POPULATION   (n=146) 
Literacy Number of Patients Percentage 
Literate 97 66.44 % 
Illiterate 49 33.56 % 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3 – LITERACY AMONG THE STUDY POPULATION (n=146) 
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6.4 BODY MASS INDEX AMONG THE STUDY POPULATION     
 A total of 146 patients, 33.56% (49 patients) were in normal body weight, 
4.79%  (7 patients) were underweight, 54.79% (80 patients) were overweight and 
6.85%  (10 patients) were obese. (Table 4, Figure 4) 
 
 
TABLE 4 : BMI AMONG THE STUDY POPULATION (n=146) 
BMI Number of Patients Percentage 
Underweight 7 4.79% 
Normal 49 33.56% 
Overweight 80 54.79% 
Obese 10 6.85% 
 
 
 
 
FIGURE 4 : BMI AMONG THE STUDY POPULATION   (n=146) 
6.5 SOCIAL HISTORY AMONG THE STUDY POPULATION 
 Among 146 patients, 26.71% (39 patients) were smokers and 73.29% 
(107 patients) were non smokers whereas 35.62% (52 patients) was having  
history of alcohol intake and 64.38% (94 patients) was not having history of 
alcohol intake.(Table 5,figure 5) 
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TABLE 5: HISTORY OF SMOKING AND ALCOHOL INTAKE AMONG THE 
STUDY POPULATION    (n=146) 
 
History of Smoking 
And Alcohol Intake 
Number of Patients Percentage 
Smokers 39 26.71% 
Alcoholic 52 35.62% 
Non-smokers 107 73.29% 
Non-alcoholic 94 64.38% 
 
 
FIGURE 5: HISTORY OF SMOKING AND ALCOHOL INTAKE AMONG THE 
STUDY POPULATION (n=146) 
 
6.6 DURATION OF DIABETES MELLITUS AMONG THE STUDY 
POPULATION     
 A total of 146 patients, 59.59% (87 patients) were having 6-10 years 
duration of DM, 15.07% (22 patients) were having 5 years duration of DM, 
13.01% (19 patients) were having 11-15 years duration of DM, 5.48% (8 
patients) were having 16-20 years duration of DM, 4.11% (6 patients) were 
having 21-25 years duration of DM, 2.74% (4 patients) were having >25 years 
duration of DM. Therefore most of the patients were suffering for 6-10 years 
duration of DM.(Table 6,figure 6) 
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TABLE 6: DURATION OF DIABETES MELLITUS AMONG THE STUDY 
POPULATION (n=146) 
 
Duration of Diabetes Number of Patients Percentage 
5 years 22 15.07% 
6-10 years 87 59.59% 
11-15 years 19 13.01% 
16-20 years 8 5.48% 
21-25 years 6 4.11% 
>25 years 4 2.74% 
 
 
 
 
 
 
 
 
 
 
FIGURE 6: DURATION OF DIABETES MELLITUS AMONG THE STUDY 
POPULATION (n=146) 
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6.7 PATTERN OF CO-MORBIDITIES PREVALENCE AMONG THE STUDY 
POPULATION  
 A total of 146 patients, 36.30% (53 patients) have diabetes mellitus, 
41.78% (61 patients) have diabetes mellitus with hypertension, 21.92% (32 
patients) have diabetes mellitus with other complications.(Table 7,figure 7) 
 
TABLE 7: PATTERN OF CO-MORBIDITIES PREVALENCE AMONG THE 
STUDY POPULATION (n=146) 
Co-Morbidities Number of Patients Percentage 
Diabetes Mellitus 53 36.30% 
DM + Hypertension 61 41.78% 
DM + Others 32 21.92% 
 
 
 
FIGURE 7: PATTERN OF CO-MORBIDITIES PREVALENCE AMONG THE 
STUDY POPULATION    (n=146) 
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6.8 PREVALENCE OF DIABETIC FOOT ULCER AMONG THE STUDY 
POPULATION 
 Among 146 study population, 27.40% (40 patients) have foot ulcer 
currently remaining 72.60% (106 patients) were without foot ulcer.(Table 
8,figure 8) 
 
 
TABLE 8: PREVALENCE OF DIABETIC FOOT ULCER AMONG THE 
STUDY POPULATION      (n=146) 
 Number of Patients Percentage 
Patients with foot ulcer 40 27.40% 
Patients without foot ulcer 106 72.60% 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 8: PREVALENCE OF DIABETIC FOOT ULCER AMONG THE 
STUDY POPULATION  (n=146) 
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6.9 AGE WISE DISTRIBUTION OF PATIENTS WHEN FOOT ULCER WAS             
FOUND 
 Patients in the age group of 51-60 years(40%) was more susceptible to 
foot ulcer, the patients within the age group of 61-70 years(37.5%) shows next 
susceptibility, and comparatively in the age group of 36-50 years it was less. 
(Table 9, Figure 9) 
 
TABLE 9: AGE WISE DISTRIBUTION OF FOOT ULCER PATIENTS    
(n=40) 
Age in years Number of Patients Percentage 
36-50 4 10% 
51-60 16 40% 
61-70 15 37.5% 
>70 5 12.5% 
 
 
 
FIGURE 9: AGE WISE DISTRIBUTION OF FOOT ULCER PATIENTS   
(n=40) 
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6.10 TYPES OF TREATMENT IN DIABETIC FOOT ULCER PATIENTS 
         Among 40 diabetic foot ulcer patients, 52.5% (21 patients) were taking 
OHA’s, (37.5%) 15 patients were taking both OHA’s and insulin. Only 10%           
(4 patients) patients were taking insulin. (Table 10, Figure 10) 
 
TABLE 10: TYPES OF TREATMENT IN DIABETIC FOOT ULCER 
PATIENTS (n=40) 
Types Of Treatment No of Patients Percentage 
Insulin 4 10% 
OHA’s 21 52.5% 
Both 15 37.5% 
 
 
 
FIGURE 10: TYPES OF TREATMENT IN DIABETIC FOOT ULCER 
PATIENTS      (n=40) 
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6.11 QUALITY OF LIFE AMONG TYPE 2 DIABETES PATIENTS WITH 
RESPECT TO DURATION OF DM, TREATMENT REGIMEN AND                  
CO-MORBIDITIES  
 The mean score of overall quality of life at baseline was 17.44 ± 1.50 
and at final follow up was 21.02 ± 2.12 which shows a significant difference 
among the participants (p <0.05). (Table 11)  
 
TABLE   11:  QOL OF LIFE AMONG TYPE 2 DIABETES MELLITUS     
(n=40) 
 
QOL Domains 
 
Baseline 
Follow ups 
1st visit 2nd visit 3rd visit 
 
Overall QOL 
 
 
17.44±1.50 
 
 
18.44±1.18 
 
19.88±1.69 
 
21.02±2.12 
 
Health and 
Functioning 
 
 
16.72±1.67 
 
18.41±1.61 
 
 
20.01±2.09 
 
20.82±1.82 
 
Social and 
Economical 
 
 
18.19±2.73 
 
18.74±1.72 
 
19.87±2.29 
 
21.41±1.93 
 
Psychological 
 
 
18.03±2.36 
 
19.41±2.56 
 
19.94±2.41 
 
21.18±2.96 
 
Family 
 
 
18.32±3.67 
 
19.1±2.69 
 
20.7±2.99 
 
20.67±2.48 
QOL - QUALITY OF LIFE 
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 The mean and standard deviation of overall QOL with respect to the 
domains of QOL, have a significant (p ˂0.05) for health and functioning, 
social and economic, psychological/spiritual, and family. 
6.12 THE IMPACT OF DURATION OF DM ON HEALTH AND 
FUNCTIONING DOMAIN BY COMPARISON OF MEAN AFTER PATIENT 
COUNSELLING 
           The patients having 5-9 years and 10-14 years duration of diabetes 
shows significant difference (p <0.05) between baseline and follow up 1 in 
their health and functioning domain after counseling whereas patients ≥15 
years have no significant improvement (p >0.05) in the first follow up and 
further education helps them to improve quality of life shows significant 
difference in follow up 2 and 3. (Table 12, figure 11)  
TABLE 12: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
HEALTH AND FUNCTIONING DOMAIN (n=40) 
QOL 
Domains 
Duratio
n of 
DM 
Baseline 
Follow ups 
1st visit 2nd visit 3rd visit 
 
 
 
Health and 
Functioning 
 
5-9 
years 
 
 
16.60±1.59 
 
18.36±1.85* 
 
19.94±2.23* 
 
20.77±1.85* 
 
10-14 
years 
 
 
16.44±1.38 
 
18.5±1.06* 
 
19.68±1.72* 
 
20.52±1.95* 
 
≥15 
years 
 
 
17.54±2.07 
 
18.13±1.64ns 
 
20.82±2.07* 
 
21.51±1.21* 
 
*P<0.05, ns-not significant 
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FIGURE 11: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
HEALTH AND FUNCTIONING DOMAIN    (n=40) 
 
6.13 THE IMPACT OF DURATION OF DM ON SOCIAL AND ECONOMICAL 
DOMAIN BY COMPARISON OF MEAN AFTER PATIENT COUNSELLING 
         In social and economical domain, there were no significant differences 
between baseline and follow up 1 in patients having duration of DM for 5-9 
years. After the second counseling, There was a significant difference                 
(p <0.05).  10-14 years duration of DM patients shows significance only after 
third counseling. The patients having more than 15 years of DM were not 
significant socially and economically (p >0.05). Finally, 5-9 years duration of 
DM patients have better quality of life when compared to others. (Table 13, 
figure 12) 
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TABLE  13: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
SOCIAL AND ECONOMICAL DOMAIN    (n=40) 
QOL 
Domains 
Duration 
of DM 
Baseline 
Follow ups 
1st visit 2nd visit 3rd visit 
Social and 
Economical 
5-9 years 17.42±2.72 18.57±1.50ns 19.81±2.35* 21.17±1.90* 
10-14 
years 
18.54±2.31 18.94±1.78ns 19.75±2.52ns 21.42±1.66* 
≥15 years 19.76±2.66 18.82±2.13ns 20.25±1.43ns 22.10±2.27ns 
*P<0.05, ns-not significant 
 
FIGURE12: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
SOCIAL AND ECONOMICAL DOMAIN (n=40) 
 
6.14 THE IMPACT OF DURATION OF DM ON PSYCHOLOGICAL AND 
SPIRITUAL DOMAIN BY COMPARISON OF MEAN AFTER PATIENT 
COUNSELLING 
 The patients with 5-9 years duration of DM have no significant 
difference in follow up 1 (p >0.05). But after counseling, there shows a 
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difference in significance (p <0.05). 10-14 years duration had significant 
difference in their psychological domain only at the follow up 3 (p  <0.05). The 
mean values obtained for the patients having ≥15 years duration of DM was 
not significant in all the three follow ups. (Table 14, Figure 13) 
 
TABLE 14: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
PSYCHOLOGICAL AND SPIRITUAL DOMAIN (n=40) 
 
QOL Domains 
 
Duration 
of DM 
 
Baseline 
Follow ups 
1st visit 2nd visit 3rd visit 
Psychological/ 
Spiritual 
5-9 years 17.66±2.23 20.17±2.54ns 20.52±2.14* 20.51±3.29* 
10-14 
years 
18.16±2.38 18.64±2.33ns 19.01±2.66ns 20.83±2.26* 
≥15 
years 
18.84±2.48 18.66±2.36ns 20.01±2.09ns 21.92±2.23ns 
*P<0.05, ns-not significant 
 
 
FIGURE 13: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
PSYCHOLOGICAL / SPIRITUAL DOMAIN   (n=40) 
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6.15 THE IMPACT OF DURATION OF DM ON FAMILY DOMAIN BY 
COMPARISON OF MEAN AFTER PATIENT COUNSELING 
 5-9 years duration of DM patients had no significant changes over 
follow up 1  (p >0.05) and after second counseling, the patient shows 
significant changes over follow up 2 which indicates the improvement of 
quality of life in the family domain. The patients  with 10-14 years of DM does 
not have significance till the second follow up whereas after educating them 
for second time shows significant difference in their follow up 3    (p <0.05). 
The patients having ≥15 years duration of DM shows no significant 
differences in all the three follow ups (p > 0.05). (Table 15, figure 14) 
 
TABLE 15: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
FAMILY DOMAIN (n=40) 
 
*P<0.05, ns-not significant 
 
QOL 
Domains 
 
Duration 
of DM 
 
Baseline 
Follow ups 
1st visit 2nd visit 3rd visit 
 
Family 
5-9 years 17.50±3.38 18.70±2.51ns 20.83±2.96* 20.79±2.24* 
10-14 
years 
18.32±3.54 20.52±2.4ns 20.03±2.71ns 19.85±2.88* 
≥15 
years 
20.67±3.72 20.54±2.73ns 21.57±3.28ns 21.83±1.64ns 
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FIGURE 14: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
FAMILY DOMAIN (n=40) 
 
 
6.16 THE IMPACT OF TREATMENT REGIMEN ON HEALTH AND 
FUNCTIONING DOMAIN BY COMPARISON OF MEAN AFTER PATIENT 
COUNSELLING  
 The patients with all types of treatment shows significant improvement 
over health and functioning domain in all the follow ups with baseline. This 
result shows that their medication adherence is good and moreover 
counseling helped them in the aspect of managing the medication compliance 
(Table 16,figure 15) 
 
  
0
5
10
15
20
25
Baseline Follow up 1 Follow up 2 Follow up 3
FAMILY 
5-9 years
10-14 years
≥ 15 years 
Results 
 
A Study on Prevalence of Diabetic Foot Ulcer and Quality of Life of Type  2 Diabetes  
Mellitus Patients in a Multi-speciality Hospital Page 42 
 
TABLE 16: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
HEALTH AND FUNCTIONING DOMAIN (n=40) 
 
*P<0.05, ns-not significant 
 
 
 
FIGURE 15: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
HEALTH AND FUNCTIONING DOMAIN    (n=40) 
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QOL 
Domains 
 
Items 
 
Baseline 
Follow ups 
1st visit 2nd visit 3rd visit 
Health and 
Functioning 
Insulin 15.38±0.48 17.88±0.72* 21.05±2.41* 20.87±1.97* 
OHA’s 17.12±1.93 18.89±1.81* 19.58±1.95* 20.84±2.03* 
Both 16.50±1.17 17.88±1.21* 20.34±2.03* 20.79±1.44* 
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6.17 THE IMPACT OF TREATMENT REGIMEN ON SOCIAL AND 
ECONOMICAL DOMAIN BY COMPARISON OF MEAN AFTER PATIENT 
COUNSELING  
 Patients were on all the types of treatment does not show significant 
improvement over social and economical domain in their follow up 1(p >0.05) 
whereas in their further follow ups they show a gradual significant differences 
in their social life (p <0.05). (Table 17, Figure 16). 
TABLE 17: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
SOCIAL AND ECONOMICAL DOMAIN    (n=40) 
*P<0.05, ns-not significant 
 
FIGURE 16: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
SOCIAL AND ECONOMICAL DOMAIN    (n=40) 
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1st visit 2nd visit 3rd visit 
 
 
Social and 
Economical 
Insulin 17.83±2.44 19.64±1.81ns 19.23±1.79* 20.55±1.49* 
 
OHA’s 18.05±2.95 18.84±1.64ns 20.10±2.21* 21.44±1.82* 
 
Both 18.50±2.43 18.34±1..85ns 19.71±2.46* 21.61±2.12* 
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6.18 THE IMPACT OF TREATMENT REGIMEN ON PSYCHOLOGICAL OR 
SPIRITUAL DOMAIN BY COMPARISON OF MEAN AFTER PATIENT 
COUNSELING 
 The insulin taking patients does not show any significant difference 
between baseline and follow up 1. The patients were counseled for second 
time and in their third follow up the significant difference was seen (p <0.05). 
Patients taking OHAs shows their significance after three counseling, there 
was an improvement in their QOL. The patients taking both insulin and OHA’s 
shows significant differences between baseline and follow up 2, final follow 
up.(Table 18,figure 17) 
 
TABLE 18: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
PSYCHOLOGICAL /SPIRITUAL DOMAIN  (n=40) 
*P<0.05, ns-not significant 
  
 
QOL Domains 
 
Items 
 
Baseline  
Follow ups 
1st visit 2nd visit 3rd visit 
 
 
Psychological/ 
Spiritual 
Insulin 16.86±3.28 20.05±1.76ns 21.37±0.56* 23.07±3.03* 
 
OHA’s 18.59±2.12 19.68±2.47ns 19.61±1.78ns 21.34±2.73* 
 
Both 17.56±2.18 18.86±2.75ns 20.01±3.20* 20.46±2.83* 
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FIGURE 17: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
PSYCHOLOGICAL/SPIRITUAL DOMAIN (n=40) 
 
6.19 THE IMPACT OF TREATMENT REGIMEN ON FAMILY DOMAIN BY 
COMPARISON OF MEAN AFTERPATIENTCOUNSELING 
 The patients were on insulin treatment shows significant improvement 
compared to other types of treatment (p <0.05). Patients taking OHA’s or both 
the medication does not have significant improvement in their family domain 
(p >0.05). Therefore in this study, insulin taking patients have good family 
support than others. (Table 19,Figure 18) 
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TABLE 19 : COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
FAMILY DOMAIN     (n=40) 
*P<0.05, ns-not significant 
 
 
 
FIGURE 18: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
FAMILY DOMAIN          (n=40) 
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Follow ups 
1st visit 2nd visit 
3rd visit 
 
 
Family 
Insulin 14.96±0.92 20.3±2.10* 21.96±3.19* 22.68±2.19* 
OHA’s 18.37±3.44 19.61±2.73ns 20.15±3.10ns 20.27±2.51ns 
Both 19.14±3.95 19.43±2.79ns 21.12±2.57ns 20.69±2.23ns 
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6.20 THE IMPACT OF CO-MORBIDITIES ON HEALTH AND FUNCTIONING 
DOMAIN BY COMPARISON OF MEAN AFTER PATIENT COUNSELING 
 Though the patients having co-morbidities their health and functioning 
remains same as the patients without having co-morbidities. The counseling 
has done for the patients have less attitude towards their physical strength. 
There was a significant difference between baseline and all the three follow 
ups (p <0.05). (Table 20, Figure 19) 
 
TABLE 20: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
HEALTH AND FUNCTIONING DOMAIN        (n=40) 
 
 
QOL 
Domains 
 
Items 
 
Baseline 
Follow ups 
1st visit 2nd visit 3rd visit 
 
 
Health and 
Functioning 
 
With 
comorbidities 
 
16.05±1.19 
 
18.27±1.82* 
 
19.74±2.26* 
 
20.09±1.19* 
 
Without 
comorbidities 
 
17.21±1.80 
 
18.52±1.42* 
 
20.21±1.93* 
 
21.36±2.01* 
*P<0.05, ns-not significant 
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FIGURE 19: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
HEALTH AND FUNCTIONING DOMAIN       (n=40) 
 
6.21 THE IMPACT OF CO-MORBIDITIES ON SOCIAL AND ECONOMICAL 
DOMAIN BY COMPARISON OF MEAN AFTER PATIENT COUNSELING 
 Those patients having co-morbidities have no significant differences 
among their follow ups 1 and 2 with baseline values (p > 0.05) whereas in 
third follow up there was a significant improvement in their social and 
economical subscale values indicates quality of life was improved in their 
social life. No co-morbid patients shows significant improvement on their first 
follow up itself (p <0.05).  
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TABLE 21: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
SOCIAL AND ECONOMICAL DOMAIN (n=40) 
 
QOL 
Domains 
 
Items 
 
Baseline 
Follow ups 
1st visit 2nd visit 3rd visit 
Social and 
Economical 
With 
comorbidities 
 
18.01±2.54 
 
18.82±1.90ns 
 
19.00±1.43ns 
 
20.99±1.71* 
Without 
comorbidities 
 
18.32±2.85 
 
18.67±1.58ns 
 
20.51±2.57* 
 
21.73±2.02* 
*P<0.05, ns-not significant 
 
 
 
FIGURE 20: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
SOCIAL AND ECONOMICAL DOMAIN            (n=40) 
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6.22 THE IMPACT OF CO-MORBIDITIES ON PSYCHOLOGICAL OR 
SPIRITUAL DOMAIN BY COMPARISON OF MEAN AFTER PATIENT 
COUNSELING 
 The patients with co-morbid conditions shows their significant 
difference only after third counseling i.e in final follow up they shows their 
significant improvement in psychological domain. The diabetic patients with 
no co-morbid conditions seems better quality of life compared to the patients 
having co-morbid conditions. 
TABLE 22: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON  
PSYCHOLOGICAL/SPIRITUAL DOMAIN  (n=40) 
 
QOL Domains 
 
Items 
 
Baseline 
Follow ups 
1
st
 visit 2
nd
 visit 
3
rd
 visit 
 
 
Psychological/ 
Spiritual 
With 
comorbidities 
 
 
17.99±2.58 
 
18.64±2.50
 ns
 
 
19.38±2.23
 ns
 
 
21.34±2.45* 
 
Without 
comorbidities 
 
 
18.06±2.19 
 
19.98±2.45* 
 
20.35±2.45* 
 
21.07±3.18* 
*P<0.05, ns-not significant 
 
FIGURE 21: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
PSYCHOLOGICAL/SPIRITUAL  DOMAIN (n=40) 
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6.23 : THE IMPACT OF CO-MORBIDITIES ON FAMILY DOMAIN BY 
COMPARISON OF MEAN AFTER PATIENT COUNSELING 
 The impact of co-morbidities on family domain shows that family 
support is high in those patients having co-morbid conditions. Therefore, 
significant differences seen in all the follow ups whereas the patient without 
co-morbid conditions shows significant improvement (p <0.05) in their follow 
up 1 and final follow up. 
TABLE 23: COMPARISON OF EFFECT OF PATIENT COUNSELLING ON 
FAMILY DOMAIN        (n=40) 
 
QOL 
Domains 
 
Items 
 
Baseline 
Follow ups 
1st visit 2nd visit 
3rd visit 
 
 
 
Family 
With 
comorbidities 
 
18.14±3.27 
 
20.62±2.74* 
 
20.78±3.22* 
 
21.25±2.21* 
Without 
comorbidities 
18.45±3.94 18.87±2.39 ns 20.64±2.81* 20.23±2.58ns 
*P<0.05, ns-not significant 
 
FIGURE 22: COMPARISON OF EFFECT OF PATIENT COUNSELLINGON 
FAMILY DOMAIN  (n=40) 
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18.5
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7. DISCUSSION 
The pharmacist involvement in diabetes care is justified by his or her 
position as a key member of the health care team. He or she needs to work 
together with other health professionals to prevent diabetes and its 
complications. 
             The study comprised of 146 patients, out of which, most patients were 
in the age group of 60-69 years. In this study, the male patients (60%) were 
more predominant in number than the female patients. A study conducted by 
Bedilu Deribe et al. showed the mean age of the study population was 50.72 ± 
13.39 years. With regard to gender distribution 59.7% were males.(12) 
             A study conducted by Adepu Ramesh et al. shows that majority of the 
patients were having normal body mass index. In present study majority of the 
patients were overweight (54.79%).(23)  
            In this study, out of 146 diabetic patients attended hospital, 27.40% 
were having foot ulcer. A cross sectional study carried out by Kahsu 
Gebrekirstos et al. found that 12% were having foot ulcer. Another study 
conducted by Bedilu Deribe et al, observed 14.8% foot ulcer patients among 
216 diabetic patients.(10,12) 
            In present study 93 patients has comorbidities where the DM with 
hypertensive patients was high (41.78%). A study conducted by M. Porojan et 
al. reported that 83.3% of the diabetic participants has co-morbid diseases 
and the most commonly reported disease was hypertension (46.1%) followed 
by hyperlipidemia (6.1%). Another study conducted by Elham Ghasemi et al. 
findings shows comorbidity was frequent (96%). Similar study conducted by 
Anumol Mathew et al shows  63% of subjects had co-morbid illness. (6,50,68) 
            When this overall quality of life score was broken down into four 
subscales would became apparent that the respondents were least satisfied 
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with their health followed by their social and economic aspects and were most 
satisfied with their psychological/spiritual aspects followed by family aspects.  
            In the analysis of the impact of diabetes on QOL for different domains, 
the greatest negative impact of T2DM with ≥15 years duration and oral 
hypoglycemic agents was observed M. Porojan et al. conducted a study and 
their result shows that the duration of diabetes and insulin therapy had a 
significant impact on life quality among the diabetic patients.(50) 
            In this study, patients with oral hypoglycemic agents have less quality 
of life than who were on insulin, and both medication Abuawad Majed S. S et 
al. found that patients who were on oral hypoglycemic agents (OHAs) only 
had a better HRQOL than who were on insulin, but this difference did not 
reach the significant level for longer duration of DM (> 10 years). (71) 
            In this study, the effect of insulin does not affect the Quality of life of 
patients compared to other types of treatment. M. Porojan et al. examining the 
effects of insulin use and QOL, there are no significant differences between 
patients following insulin therapy and patients with other therapeutic 
protocols.(50) 
            Based on the findings, participants had average levels of QOL. These 
findings showed that QOL in type 2 diabetes mellitus patients needs 
improvement through educating the patients regarding their disease condition. 
            The present study has the patient without comorbidities shows better 
quality of life when compared to patients have co-morbid condition. Results 
also agreed with the study Abuwad S.S. Majed et al., found that patients who 
did not develop any complications had better means of the QOL domains than 
those who had only one complication.(71) 
            The present study has the patient without comorbidities shows better 
quality of life when compared to patients have co-morbid condition. Results 
also agreed with the study Abuwad S.S. Majed et al., found that patients who 
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did not develop any complications had better means of the QOL domains than 
those who had only one complication. (71) 
            Abuwad S.S. Majed et al., results in the effect of the treatment of DM 
on the QOL, that the means of all QOL domains for diabetic patients who 
were treated by OHAs were slightly better than those who were treated by 
Insulin. (71) 
            These results are in conflict with the research that has shown 
increasing treatment intensity in patients with type II DM from diet and 
exercise alone, to oral medications, to insulin, is associated with worsening 
QOL, Rubin and Peyrot et al.(70) 
            In this study patients with insulin therapy shows better quality of life 
than patients were on OHA’s. In regard to the type of insulin therapy, 
Chantelau et al. studied in two patient groups. In cohort A, intensified their 
traditional insulin injection with syringe to injections with insulin-pen. In cohort 
B, changed from intensive therapy with pen to insulin pump-treatment. 
Treatment satisfaction increased after intensification of insulin therapy in both 
groups, due to greater flexibility with leisure-time activities, and with the 
diet.(69) 
            Regarding the duration of DM and QOL, Directly after diagnosis, the 
patients suffered from the psychological shock and they were not able to 
accept or adapt to the new situation; this is why their QOL values decreased 
in the first years of diagnosis. But after 5 years, they started to psychologically 
accept the condition and adapt to their disease and manage it correctly, as a 
result, their QOL means had improved. Finally, when DM extends to more 
than 10 years and the patients started to develop complications. 
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8. CONCLUSION 
 The prevalence of diabetic patients have foot ulcer was 27.40%. The 
patients with mean age group of 55.5 ± 03.03 years were more prone to the 
diabetic foot ulcer. 
The present study concludes that participants had average levels of 
overall quality of life. The quality of life could be improved through the patient 
education regarding their disease condition and drugs used. The main factors 
associated with poor QOL were duration of diabetes mellitus and co-morbid 
conditions. 
The psychological domain of quality of life was most affected 
significantly for the patients having longer duration of disease condition 
particularly for the patients with more than 15 years of diabetes mellitus. 
As per the study, with regular patient counseling maintenance of diet 
and exercise with good patient compliance improves the quality of life of 
patients in day-to-day activities and that has reduced the morbidity and 
mortality rate. Educating the patient is an important aspect to prevent the 
disease and promote the health of the individuals. 
The diabetes have an adverse effect on the quality of life of the 
patients. The study suggested that the regular medication, creating self-help 
groups, physical activity, good glycemic control may help to improve the 
quality of life. 
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Swamy Vivekanandha College of Pharmacy 
Institutional Human Ethics Committee 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS 
 
(strike off items that are not applicable) 
 
 
I, Parkavi Rani.P  Am carrying out a study on the topic: A study on Prevalence of Diabetic Foot Ulcer and 
Quality of Life of Type 2 Diabetes Mellitus Patients in a Multi specialty Hospital. 
 
as part of my / our research project being carried out under the aegis of the Department of: Pharmacy Practice 
my research guide is:  DR. T. TAMIL SELVAN 
The justification for this study is: Predicts an Individual’s capacity to manage his disease and maintain 
long term health and wellbeing. 
 
 
The objectives of this study are:  
 
Primary Objective: To assess the prevalence of diabetic foot ulcer 
 
Secondary Objective: To evaluate the quality of life in type 2 diabetes mellitus patients  
 
 
Sample size: 150 patients (app) 
 
Study volunteers / participants are (specify population group & age group): Patients with type 2 DM of age 
≥30 years  
 
Location: Vivekanandha medical care hospital 
 
We request you to kindly cooperate with us in this study. We propose collect background information and other 
relevant details related to this study. We will be carrying out:  
 
Initial interview (specify approximate duration): 10-15 minutes.  
 
Data collected will be stored for a period of fifteen years. We will / will not use the data as part of another study. 
 
Health education sessions: Number of sessions: 3. Approximate duration of each session: 15 minutes.  
 
Clinical examination (Specify details and purpose): NA 
 
Blood sample collection: Specify quantity of blood being drawn: ___________ml. 
 
No. of times it will be collected: _______________.  
 
Whether blood sample collection is part of routine procedure or for research (study) purpose:   
 
1. Routine procedure 2. Research purpose  
 
Specify purpose, discomfort likely to be felt and side effects, if any: _______________________________ 
 
Whether blood sample collected will be stored after study period: Yes / No, it will be destroyed 
Study Volunteer ID:                                                   
Study Volunteer Name:  
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Whether blood sample collected will be sold: Yes / No  
 
Whether blood sample collected will be shared with persons from another institution: Yes / No 
 
Medication given, if any, duration, side effects, purpose, benefits:  
 
Whether medication given is part of routine procedure: Yes / No (If not, state reasons for giving this medication) 
 
Whether alternatives are available for medication given: Yes / No (If not, state reasons for giving this particular 
medication) 
 
Final interview (specify approximate duration): 15 mts. If photograph is taken, purpose:  
 
Benefits from this study: To increase the quality of life among  type 2 diabetic patients. 
 
Risks involved by participating in this study: NIL 
 
How the results will be used:  
 
If you are uncomfortable in answering any of our questions during the course of the interview / biological sample 
collection, you have the right to withdraw from the interview / study at anytime. You have the freedom to 
withdraw from the study at any point of time. Kindly be assured that your refusal to participate or withdrawal at 
any stage, if you so decide, will not result in any form of compromise or discrimination in the services offered nor 
would it attract any penalty. You will continue to have access to the regular services offered to a patient. You will 
NOT be paid any remuneration for the time you spend with us for this interview / study. The information 
provided by you will be kept in strict confidence. Under no circumstances shall we reveal the identity of the 
respondent or their families to anyone. The information that we collect shall be used for approved research 
purposes only. You will be informed about any significant new findings - including adverse events, if any, – 
whether directly related to you or to other participants of this study, developed during the course of this research 
which may relate to your willingness to continue participation. 
 
Consent: The above information regarding the study, has been read by me/ read to me, and has been 
explained to me by the investigator/s. Having understood the same, I hereby give my consent to them to 
interview me. I am affixing my signature / left thumb impression to indicate my consent and willingness to 
participate in this study (i.e., willingly abide by the project requirements).  
 
Signature / Left thumb impression of the Study Volunteer / Legal Representative:  
 
 
 
Signature of the Interviewer with date:      Witness: 
 
Contact number of PI: 08012291431 
Xg;Gjy; gbtk; 
Njjp: 
 
-----------------------------------------------------------  Mfpaehd;> VMCH kUj;Jtkidapy; -------------
------------------------------------------------------ Jiwapd; fPo;> ------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------------------
--- vd;wjiyg;gpy;Ma;TNkw;nfhs;scs;Nsd;. 
 
vd; Ma;Ttopfhl;b: 
 
Ma;TNkw;nfhs;tjw;fhdmbg;gil: 
 
 
Ma;tpd; Nehf;fk;: 
 
 
Ma;TNkw;nfhs;Sk; ,lk;: 
 
Ma;tpd; gyd;fs;: 
 
 ,e;jMa;tpy; fpilf;Fk; jfty;fs; -------------- tUlq;fs; ghJfhf;fg;gLk;.  
,it NtWve;jMa;tpw;Fk; gad;gLj;jg; glkhl;lhJ. ve;jepiyapYk; cq;fisg; 
gw;wpajfty;fs; ahUf;Fk; njhptpf;fg;glkhl;lhJ. mit 
,ufrpakhfitf;fg;gLk;. 
 ,e;jMa;tpy; gq;Nfw;fxg;Gf;nfhs;Stjhy; ve;jtpjkhdgyDk; 
cq;fSf;Ff; fpilf;fhJ.  ve;jNeuj;jpy; Ntz;LkhdhYk; Ma;tpypUe;Jtpyfpf; 
nfhs;Sk; chpikcq;fSf;Fcz;L. 
 Ma;tpypUe;J tpyfpf;nfhs;tjhy; cq;fSf;F mspf;fg;gLk; rpfpr;irapy; 
ve;j tpj khw;wKk; ,Uf;fhJ. 
 ,e;j Muha;r;rpf;fhf cq;fsplk; rpy Nfs;tpfs; Nfl;fg;gLk; / rpy 
,uj;j khjphpfs; my;yJ jpR khjphpfs; vLf;fg;gLk;. 
 NkYk;> ,e;j Ma;tpy; gq;F nfhs;tJ cq;fs; nrhe;j tpUg;gk;.  ,jpy; 
ve;j tpjf; fl;lhaKk; ,y;iy.  ePq;fs; tpUg;gg;gl;lhy;> ,e;j Ma;tpd; 
KbTfs; cq;fSf;Fj; njhpag;gLj;jg;gLk;. 
 
 
Ma;thshpd; ifnahg;gk; : 
 
Njjp    : 
 
Ma;Tf;Fl;gLgthpd; xg;Gjy;: 
 
 ehd; ,e;jMuha;r;rpapd; Nehf;fk; kw;Wk; mjd; gad;ghl;bidg; 
gw;wpnjspthfTk;>tpsf;fkhfTk; njhpag;gLj;jg; gl;Ls;Nsd;.  ,e;jMuha;r;rpapy; 
gq;Fnfhs;sTk;> ,e;jMuha;r;rpapd; kUj;JtuPjpahdFwpg;GfistUk; fhyj;jpYk; 
cgNahfg;gLj;jpf; nfhs;sTk; KO kdJld; rk;kjpf;fpNwd;. 
 
Ma;Tf;Fl;gLgthpd; ngah;>Kfthp : 
 
 
 
  ifnahg;gk; : 
  
   Njjp  : 
DATA ENTRY FORM 
 
NAME                                                                            IP NO/OP NO 
AGE /SEX          DOA 
HEIGHT                                                                         WEIGHT 
BMI   MARITAL STATUS 
EDUCATIONAL STATUS   OCCUPATION 
REASON FOR ADMISSION 
 
PAST MEDICAL HISTORY 
TYPE OF DIABETES                                                     DURATION OF DIABETES 
PAST MEDICATION HISTORY 
 
FAMILY HISTORY 
SOCIAL HABITS  
SMOKER                                               TOBACCO 
ALCOHOLIC          NONE 
 
BLOOD GLUCOSE PROFILE 
DATE I VISIT II VISIT III VISIT 
FBS(60-90)    
RBS(90-110)    
PPBS(80-150)    
 
 
DIABETIC FOOT SCREENING: 
RIGHT FOOT 
 
LEFT  FOOT 
 
DURATION OF ULCER                                                           SIZE OF ULCER 
 
DIAGNOSIS 
 
OTHERS 
 
TREATMENT 
 
Ferrans and Powers 
QUALITY OF LIFE INDEX© 
DIABETES VERSION - III 
 
PART 1. For each of the following, please choose the answer that best describes how satisfied you are with 
that area of your life. Please mark your answer by circling the number. There are no right or wrong 
answers. 
 
 
 
 
 
 
 
 
HOW SATISFIED ARE YOU WITH: 
 
 
1.  Your health? 1 2 3 4 5 6 
2.  Your health care? 1 2 3 4 5 6 
3.  The amount of energy you have for everyday activities? 1 2 3 4 5 6 
4.  Your ability to take care of yourself without help? 1 2 3 4 5 6 
5.  Your ability to control your blood sugar? 1 2 3 4 5 6 
6. The changes you have had to make in your life because 
of diabetes (such as diet, exercise, taking insulin or 
diabetes pill, checking blood sugar)? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
7.  The amount of control you have over your life? 1 2 3 4 5 6 
8.  Your chances of living as long as you would like? 1 2 3 4 5 6 
9.  Your family’s health? 1 2 3 4 5 6 
10.  Your children? 1 2 3 4 5 6 
11. Your family’s happiness? 1 2 3 4 5 6 
12. Your sex life? 1 2 3 4 5 6 
13. Your spouse, lover, or partner? 1 2 3 4 5 6 
14.  Your friends? 1 2 3 4 5 6 
15. The emotional support you get from your family? 1 2 3 4 5 6 
 
(Please Go To Next Page) 
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HOW SATISFIED ARE YOU WITH: 
 
16. The emotional support you get from people other 
than your family? 1 2 3 4 5 6  
17. Your ability to take care of family responsibilities? 1 2 3 4 5 6  
18. How useful you are to others? 1 2 3 4 5 6  
19. The amount of worries in your life? 1 2 3 4 5 6  
20. Your neighborhood? 1 2 3 4 5 6  
21. Your home, apartment, or place where you live? 1 2 3 4 5 6  
22. Your job (if employed)? 1 2 3 4 5 6  
23. Not having a job (if unemployed, retired, or disabled)? 1 2 3 4 5 6  
24. Your education? 1 2 3 4 5 6  
25. How well you can take care of your financial needs? 1 2 3 4 5 6  
26. The things you do for fun? 1 2 3 4 5 6  
27. Your chances for a happy future? 1 2 3 4 5 6  
28. Your peace of mind? 1 2 3 4 5 6  
29. Your faith in God? 1 2 3 4 5 6  
30. Your achievement of personal goals? 1 2 3 4 5 6  
31. Your happiness in general? 1 2 3 4 5 6  
32. Your life in general? 1 2 3 4 5 6  
33. Your personal appearance? 1 2 3 4 5 6  
34. Yourself in general? 1 2 3 4 5 6 
 
 
(Please Go To Next Page) 
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PART 2. For each of the following, please choose the answer that best describes how important that area of 
your life is to you.  Please mark your answer by circling the number.  There are no right or wrong answers. 
 
 
 
 
 
 
 
 
HOW IMPORTANT TO YOU IS: 
 
1.  Your health? 1 2 3 4 5 6 
2.  Your health care? 1 2 3 4 5 6 
3.  Having enough energy for everyday activities? 1 2 3 4 5 6 
4.  Taking care of yourself without help? 1 2 3 4 5 6 
5.  Controlling your blood sugar? 1 2 3 4 5 6 
6. The changes you have had to make in your life because of 
diabetes (such as diet, exercise, taking insulin or diabetes pill, 
checking blood sugar? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
7.  Having control over your life? 1 2 3 4 5 6 
8.  Living as long as you would like? 1 2 3 4 5 6 
9.  Your family’s health? 1 2 3 4 5 6 
10.  Your children? 1 2 3 4 5 6 
11. Your family’s happiness? 1 2 3 4 5 6 
12. Your sex life? 1 2 3 4 5 6 
13. Your spouse, lover, or partner? 1 2 3 4 5 6 
14.  Your friends? 1 2 3 4 5 6 
15. The emotional support you get from your family? 1 2 3 4 5 6 
16. The emotional support you get from people other 
than your family? 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
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HOW IMPORTANT TO YOU IS:  
17. Taking care of family responsibilities? 1 2 3 4 5 6 
18. Being useful to others? 1 2 3 4 5 6 
19. Having no worries? 1 2 3 4 5 6 
20. Your neighborhood? 1 2 3 4 5 6 
21. Your home, apartment, or place where you live? 1 2 3 4 5 6 
22. Your job (if employed)? 1 2 3 4 5 6 
23. Having a job (if unemployed, retired, or disabled)? 1 2 3 4 5 6 
24. Your education? 1 2 3 4 5 6 
25. Being able to take care of your financial needs? 1 2 3 4 5 6 
26. Doing things for fun? 1 2 3 4 5 6 
27. Having a happy future? 1 2 3 4 5 6 
28. Peace of mind? 1 2 3 4 5 6 
29. Your faith in God? 1 2 3 4 5 6 
30. Achieving your personal goals? 1 2 3 4 5 6 
31. Your happiness in general? 1 2 3 4 5 6 
32. Being satisfied with life? 1 2 3 4 5 6 
33. Your personal appearance? 1 2 3 4 5 6 
34. Are you to yourself? 1 2 3 4 5 6 
 
© Copyright 1984 & 1998 Carol  Estwing Ferrans and Marjorie J. Powers 
Items for Subscales for the 
Quality of Life Index (QLI) – Diabetes III Version 
 
Five scores are calculated for the Ferrans and Powers Quality of Life Index: (1) Total Quality of Life 
Score (2) Health and functioning subscale score, (3) Social and economic subscale score, (4) 
Psychological/spiritual subscale score, and (5) Family subscale score. Items listed below are from both 
Part 1 (Satisfaction) and Part 2 (Importance).  For example, A1.  Health@ refers to question #1 in Part 1 and 
question #1 in Part 2. 
 
Total Quality of Life Score 
All of the items are used to calculate the total score, which reflects overall quality of life. 
 
Health and Functioning Subscale 
1. Health 
2. Health care 
3. Energy (fatigue) 
4. Ability to take care of yourself without help 
5. Ability to control blood sugar 
6. Changes made in life because of diabetes 
7. Control over life 
8. Chances for living as long as you would like 
12.  Sex life 
17. Ability to take care of family responsibilities 
18. Usefulness to others 
19. Worries 
26. Things for fun 
27. Chances for a happy future 
 
Social and Economic Subscale 
14. Friends 
16.  Emotional support from people other than your family 
20. Neighborhood 
21. Home 
22/23.  Job/not having a job 
24. Education 
25. Financial needs 
 
Psychological/Spiritual Subscale 
28. Peace of mind 
29. Faith in God 
30. Achievement of personal goals 
31. Happiness in general 
32. Life satisfaction in general 
33. Personal appearance 
34. Self 
 
Family Subscale 
9. Family health 
10. Children 
11. Family happiness 
13.  Spouse, lover, or partner 
15.  Emotional support from family 
 
 
 
 
